EU funded effort to develop new stroke therapies
The COUNTERSTROKE consortium, led by researchers at Karolinska Institutet in Sweden, today initiates a six million Euro EU funded collaboration to develop novel therapeutics to treat stroke.Stroke and other conditions related to a decreased oxygen supply to the brain are the third most common cause of death in Europe. One out of three stroke incidents lead to permanent damage, and stroke is a major cause of adult disability.The COUNTERSTROKE consortium, which consists of six European research institutions and companies, is pleased to announce the initiation of a grant funded research for